Position in NTRA
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$58,090
New position
Shares Held
214
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#693
of 844 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Generali Asset Management SPA SGR holds $50,673,741 across 12 Diagnostics & Research names. NTRA ranks #12 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
64,292 | $12,246,340 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
18,450 | $9,250,092 | |
| 3 | A |
Agilent Technologies, Inc.
|
51,783 | $6,878,335 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
33,926 | $6,555,181 | |
| 5 | LH |
Labcorp Holdings Inc.
|
15,711 | $4,399,080 | |
| 6 | DGX |
Quest Diagnostics Inc
|
15,146 | $3,210,194 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
5,860 | $3,084,938 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
1,642 | $2,097,671 |
All Filings in NTRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,090 | 214 | Shares | Sole | 2026-07-30 | |
| No filing history on record for this holder in this stock. | ||||||